VEGFB and pancreatic ductal adenocarcinoma: The results showed that high expression of VEGFB was positively correlated with survival probabilities in specific tumors, such as pancreatic ductal adenocarcinoma, ovarian cancer, sarcoma, esophageal squamous cell carcinoma, and others (Supplemental Figure 14A).